Treatment News : DRACO: A Broad-Spectrum Therapy Against Multiple Viruses

POZ - Health, Life and HIV
Subscribe to:
POZ magazine
E-newsletters
Join POZ: Facebook MySpace Twitter Pinterest
Tumblr Google+ Flickr MySpace
POZ Personals
Sign In / Join
Username:
Password:

Back to home » Treatment News » August 2011

Most Popular Links
Most Popular Lessons

The HIV Life Cycle

Shingles

Herpes Simplex Virus

Syphilis & Neurosyphilis

Treatments for Opportunistic Infections (OIs)

What is AIDS & HIV?

Hepatitis & HIV

15 Years Ago In POZ


More Treatment News

Click here for more news

Have news about HIV? Send press releases, news tips and other announcements to news@poz.com.


emailprint

August 12, 2011

DRACO: A Broad-Spectrum Therapy Against Multiple Viruses

Researchers at the Massachusetts Institute of Technology’s Lincoln Laboratory have developed and demonstrated a novel broad-spectrum antiviral approach, called DRACO—which stands for double-stranded RNA activated caspase oligomerizer—that may prove to be effective against virtually all viruses, including HIV and hepatitis, according to a report published online by PLoS One. DRACOs selectively induce apoptosis, or cell suicide, in cells containing any viral double-stranded RNA, rapidly killing infected cells without harming uninfected cells.

Viruses pose serious health threats worldwide. For viruses such as HIV or hepatitis, emerging viruses such as avian or swine influenza, and highly lethal viruses such as Ebola or smallpox that might be used in bioterrorist attacks, relatively few therapeutics exist. Most medications that do exist are highly specific for one virus, are ineffective against virus strains that become resistant to them, or are associated with side effects.

According to the PLoS One report, authored by Todd Rider, PhD, and his colleagues, DRACOs were shown to be effective against all 15 viruses that the team has so far tested in cells, including cold viruses (rhinoviruses), H1N1 influenza strains, adenoviruses, a stomach virus (reovirus), a polio virus, dengue fever virus, and several members of hemorrhagic fever virus families. DRACOs were also demonstrated to be nontoxic in 11 different cell types representing various species, notably humans, monkeys and mice, and organ types (for example, heart, lung, liver and kidney).

Experiments also demonstrated that one DRACO prevented the deaths of mice infected with a lethal dose of H1N1 influenza. Currently, the team is testing additional viruses in mice and beginning to get promising results with those as well. 

No data from research involving HIV or hepatitis have yet been reported by the scientists and additional testing against other viruses is needed. Yet, Rider and his colleagues suggest that DRACOs have the potential to revolutionize the treatment and prevention of virtually all viral diseases. They also hope that the DRACOs' broad-spectrum activity will render them useful against new or mutated viruses, such as the 2003 SARS outbreak.

Search: DRACO, MIT, Lincoln Laboratory, Rider, antiviral, HIV, hepatitis, HCV, Ebola, H1N1, SARS


Scroll down to comment on this story.



Name:

(will display; 2-50 characters)

Email:

(will NOT display)

City:

(will display; optional)

Comment (500 characters left):

(Note: The POZ team reviews all comments before they are posted. Please do not include either ":" or "@" in your comment. The opinions expressed by people providing comments are theirs alone. They do not necessarily reflect the opinions of Smart + Strong, which is not responsible for the accuracy of any of the information supplied by people providing comments.)

Comments require captcha.
Please enter this number for verification:

| Posting Rules



Show comments (12 total)

 
[Go to top]


Join POZ Facebook Twitter Google+ MySpace YouTube Tumblr Flickr
Quick Links
Current Issue

HIV Testing
Safer Sex
Find a Date
Newly Diagnosed
HIV 101
Disclosing Your Status
Starting Treatment
Help Paying for Meds
Search for the Cure
POZ Stories
POZ Opinion
POZ Exclusives
Read the Blogs
Visit the Forums
Job Listings
Events Calendar


    acousticmat
    Tucson
    Arizona


    slimcuteguy
    Asheville
    North Carolina


    jimmy807
    San Antonio
    Texas


    jacob2608
    Panama City Beach
    Florida
Click here to join POZ Personals!
Ask POZ Pharmacist

Talk to Us
Poll
Survey
Pop Watch

more surveys
Contact Us
We welcome your comments!
[ about Smart + Strong | about POZ | POZ advisory board | partner links | advertising policy | advertise/contact us | site map]
© 2014 Smart + Strong. All Rights Reserved. Terms of use and Your privacy.
Smart + Strong® is a registered trademark of CDM Publishing, LLC.